NEW YORK, Feb. 21 (GenomeWeb News) - Inpharmatica said today that it has licensed its Admensa Interactive suite of predictive drug absorption, distribution, metabolism, and excretion models and compound prioritization tools to biotech firm Serono.

Under the terms of the non-exclusive deal, Serono will receive a multi-site license to the Admensa technology, as well as training and ADME consulting. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.